| Unique ID issued by UMIN | UMIN000034596 |
|---|---|
| Receipt number | R000039063 |
| Scientific Title | A prospective randomized controlled trial comparing 22G and 25G Franseen needles for EUS-guided fine-needle biopsy sampling of solid pancreatic masses |
| Date of disclosure of the study information | 2018/10/22 |
| Last modified on | 2021/04/23 12:33:10 |
A prospective randomized controlled trial comparing 22G and 25G Franseen needles for EUS-guided fine-needle biopsy sampling of solid pancreatic masses
A prospective randomized controlled trial comparing 22G and 25G Franseen needles for EUS-guided fine-needle biopsy sampling of solid pancreatic masses
A prospective randomized controlled trial comparing 22G and 25G Franseen needles for EUS-guided fine-needle biopsy sampling of solid pancreatic masses
A prospective randomized controlled trial comparing 22G and 25G Franseen needles for EUS-guided fine-needle biopsy sampling of solid pancreatic masses
| Japan |
solid pancreatic masses
| Hepato-biliary-pancreatic medicine |
Malignancy
NO
To demonstrate the non-inferiority of the endoscopic ultrasound-guided tissue acquisition of 25-G Franseen needle comparing with 22-G Franseen needle in solid pancreatic masses.
Efficacy
The tissue collection rate in each needle (cellularity score: 3,4,5)
1)Histological core collection rate in each needle(cellularity score: 5)
2)The tissue collection rate based on the tumor size, location, puncture rout and each pancreatic disease
3)Onsite diagnostic adequacy in each needle
4)Diagnostic accuracy in each needle
5)Specimen bloodiness in each needle
6)Ease of puncture in each needle
7)Needle visibility in each needle
8)Technical success rate in each needle
9)Adverse events
Interventional
Cross-over
Randomized
Individual
Open -but assessor(s) are blinded
Active
2
Diagnosis
| Device,equipment |
In EUS-FNA, 1st puncture using 25-G Franseen needle and 2nd puncture using 22-G Franseen needle.
In EUS-FNA, 1st puncture using 22-G Franseen needle and 2nd puncture using 25-G Franseen needle.
| 20 | years-old | <= |
| Not applicable |
Male and Female
Patients with solid pancreatic masses who are referred to EUS-FNA
1)Patients with Performance status 4
2)Patients who have risk of bleeding, or with platelet count less than fifty thousand/mm2
3)Patients with anti-thrombotic agent 2 or more
4)Patients with pancreatic mass which we cannot detect by EUS
5)Pregnant woman
6)Patients less than 20 years old
7)Patients who do not agree to participate in this study
8)Patients who determined to be inappropriate
90
| 1st name | |
| Middle name | |
| Last name | Hironari Kato |
Okayama University Hospital
Department of Gastroenterology and Hepatology
2-4-1 Shikata-cho Kita-ku Okayama-city Okayama
086-235-7219
drkatocha@yahoo.co.jp
| 1st name | |
| Middle name | |
| Last name | Takeshi Tomoda |
Okayama University Hospital
Department of Gastroenterology and Hepatology
2-5-1Shikata-cho,Kita-ku Okayama-city Okayama
086-235-7219
tomotake79@yahoo.co.jp
Okayama University Hospital
None
Other
NO
| 2018 | Year | 10 | Month | 22 | Day |
Unpublished
Completed
| 2018 | Year | 11 | Month | 20 | Day |
| 2018 | Year | 11 | Month | 20 | Day |
| 2018 | Year | 11 | Month | 20 | Day |
| 2020 | Year | 12 | Month | 23 | Day |
| 2020 | Year | 12 | Month | 23 | Day |
| 2021 | Year | 01 | Month | 20 | Day |
| 2021 | Year | 01 | Month | 31 | Day |
| 2018 | Year | 10 | Month | 22 | Day |
| 2021 | Year | 04 | Month | 23 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039063